STOCK TITAN

Microvision Financials

MVIS
FY2025 annual
Revenue $1.2M -74.3% YoY
Net Income -$95.0M +2.0% YoY
EPS (Diluted) -$0.35 +23.9% YoY
Free Cash Flow -$59.4M +13.8% YoY
Source SEC Filings (10-K/10-Q) Data as of Jun 30, 2026 Currency USD FYE December

Microvision (MVIS) reported $1.2M in revenue for fiscal year 2025, down 74.3% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI MVIS FY2025

External financing is carrying a development-heavy cost base while revenue remains too small to absorb operating investment.

The cash pattern is more revealing than the loss alone: FY2025 operating cash flow was -$58.7M while free cash flow was -$59.4M, so nearly all cash consumption came from ongoing operations rather than heavy capital spending. Financing dependence remains central: financing provided $60.9M, yet the cash balance declined because investing outflows added to the operating deficit.

Revenue was only $1.2M in FY2025 and gross margin was -1,435.4%, showing that reported sales did not cover direct delivery costs. R&D plus SG&A consumed far more than sales, so the expense base—not volume—is currently determining earnings.

Current ratio improved from 1.8x in FY2024 to 2.7x in FY2025, giving short-term obligations more coverage. Debt-to-equity also eased from 0.7x to 0.3x, but recurring operating cash use means that improvement does not reflect self-funding.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Cash Runway Dilution R&DIntensity Revenue Progress BurnTrend BalanceSheet 52 / 100
Financial Health Score 52/100
Scored as: Emerging companies peer group

Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Microvision's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Cash Runway
29
Dilution
93
R&D Intensity
70
Revenue Progress
3
Burn Trend
49
Balance Sheet
67
Altman Z-Score Distress
-14.40

Microvision scores -14.40, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($50.8M) relative to total liabilities ($47.6M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Neutral
4/9

Microvision passes 4 of 9 financial strength tests. 1 of 4 profitability signals pass, all 3 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality No Cash Backing
N/A

Microvision reported a net loss of $95.0M while operations used $58.7M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Interest Coverage At Risk
N/A

Microvision reported an operating loss of $82.8M against $7.3M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$1.2M
YoY-74.3%
5Y CAGR-17.1%
10Y CAGR-18.4%

Microvision generated $1.2M in revenue in fiscal year 2025. This represents a decrease of 74.3% from the prior year.

EBITDA
-$77.0M
YoY+2.0%

Microvision's EBITDA was -$77.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 2.0% from the prior year.

Net Income
-$95.0M
YoY+2.0%

Microvision reported -$95.0M in net income in fiscal year 2025. This represents an increase of 2.0% from the prior year.

EPS (Diluted)
-$0.35
YoY+23.9%

Microvision earned -$0.35 per diluted share (EPS) in fiscal year 2025. This represents an increase of 23.9% from the prior year.

Cash & Balance Sheet

Free Cash Flow
-$59.4M
YoY+13.8%

Microvision recorded an outflow of $59.4M in free cash flow in fiscal year 2025, representing a cash shortfall after capex. This represents an increase of 13.8% from the prior year.

Cash & Debt
$32.4M
YoY-40.6%
5Y CAGR+13.9%
10Y CAGR+15.2%

Microvision held $32.4M in cash against $19.2M in long-term debt as of fiscal year 2025.

Shares Outstanding
20M
YoY-90.9%

Microvision had 20M shares outstanding in fiscal year 2025. This represents a decrease of 90.9% from the prior year.

Dividends Per Share

Not reported for fiscal year 2025.

Margins & Returns

Return on Equity
-171.0%
YoY+27.7pp
5Y CAGR-19.6pp

Microvision's ROE was -171.0% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 27.7 percentage points from the prior year.

Gross Margin

Not shown for fiscal year 2025: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Operating Margin

Not shown for fiscal year 2025: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Net Margin

Not shown for fiscal year 2025: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Capital Allocation

R&D Spending
$31.7M
YoY-35.3%
5Y CAGR+26.4%
10Y CAGR+13.8%

Microvision invested $31.7M in research and development in fiscal year 2025. This represents a decrease of 35.3% from the prior year.

Capital Expenditures
$679K
YoY+81.6%
5Y CAGR+11.1%

Microvision invested $679K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 81.6% from the prior year.

Share Buybacks

Not reported for fiscal year 2025.

MVIS Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

MVIS annual income statement
MetricTTMFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11
Revenue$2.9M$1.2M-74.3%$4.7M-35.3%$7.3M+993.2%$664K-73.4%$2.5M-19.1%$3.1M-65.2%$8.9M-49.5%$17.6M+82.8%$9.6M-34.7%$14.8M+60.7%$9.2M+163.6%$3.5M-40.4%$5.9M-30.0%$8.4M+48.9%$5.6M
Cost of Revenue$18.7M$18.5M+146.3%$7.5M+171.6%$2.8M+2672.0%$100K+4900.0%$2K-99.9%$1.4M-83.7%$8.6M-19.5%$10.6M+7.9%$9.9M-4.9%$10.4M+44.5%$7.2M+587.7%$1.0M-42.0%$1.8M-74.0%$6.9M-47.0%$13.1M
Gross Profit-$15.8M-$17.3M-511.9%-$2.8M-163.2%$4.5M+695.6%$564K-77.4%$2.5M+47.6%$1.7M+425.5%$322K-95.4%$7.0M+3156.6%-$228K-105.2%$4.4M+118.5%$2.0M-17.7%$2.4M-39.7%$4.1M+181.1%$1.4M+119.3%-$7.4M
R&D Expenses$46.8M$31.7M-35.3%$49.0M-13.6%$56.7M+86.5%$30.4M+26.1%$24.1M+145.0%$9.8M-47.3%$18.7M-24.3%$24.7M+63.4%$15.1M+24.4%$12.1M+39.8%$8.7M-4.3%$9.1M-14.0%$10.5M-18.0%$12.9M-15.9%$15.3M
SG&A Expenses$25.9M$20.3M-30.7%$29.3M-20.0%$36.7M+52.6%$24.0M+8.0%$22.3M+276.1%$5.9M-27.2%$8.1M-14.6%$9.5M-6.2%$10.2M+16.2%$8.7M+11.0%$7.9M+12.5%$7.0M-20.0%$8.8M-22.2%$11.3M-15.5%$13.3M
Operating Income-$101.8M-$82.8M+3.1%-$85.5M+3.8%-$88.9M-64.9%-$53.9M-22.8%-$43.9M-222.2%-$13.6M+48.6%-$26.5M+2.7%-$27.2M-6.8%-$25.5M-54.8%-$16.5M-13.1%-$14.6M-10.5%-$13.2M+12.8%-$15.1M+33.4%-$22.7M+37.1%-$36.0M
Interest Expense$6.1M$7.3M+64.3%$4.5M+5471.3%$80K+29.0%$62KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A$46K
Income Tax$113K-$84K-116.6%$507K-55.8%$1.1M$0$0$0$0$0$0$0$0$0$0$0N/A
Net Income-$114.2M-$95.0M+2.0%-$96.9M-17.0%-$82.8M-56.0%-$53.1M-22.9%-$43.2M-216.9%-$13.6M+48.5%-$26.5M+2.8%-$27.3M-6.9%-$25.5M-54.7%-$16.5M-13.3%-$14.5M+19.7%-$18.1M-37.5%-$13.2M+41.9%-$22.7M+36.6%-$35.8M
EPS (Diluted)-$0.35+23.9%-$0.46-2.2%-$0.45-40.6%-$0.32-18.5%-$0.27-$0.10N/AN/AN/AN/AN/AN/AN/AN/AN/A

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.

MVIS Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

MVIS annual balance sheet
MetricFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11
Total Assets$103.1M-14.9%$121.2M-6.5%$129.6M+12.7%$115.0M-11.7%$130.2M+519.9%$21.0M+77.5%$11.8M-48.6%$23.0M-22.6%$29.8M+48.1%$20.1M+43.2%$14.0M+17.6%$11.9M+41.4%$8.4M-34.7%$12.9M-45.8%$23.9M
Current Assets$81.1M-1.6%$82.5M-4.9%$86.8M-4.7%$91.0M-23.8%$119.4M+580.1%$17.6M+124.1%$7.8M-55.6%$17.6M-24.0%$23.2M+33.8%$17.3M+56.6%$11.1M+15.1%$9.6M+66.4%$5.8M-40.3%$9.7M-48.0%$18.7M
Cash & Equivalents$32.4M-40.6%$54.5M+20.6%$45.2M+119.9%$20.5M-75.2%$82.6M+390.1%$16.9M+188.9%$5.8M-57.6%$13.8M-18.9%$17.0M+12.1%$15.1M+91.9%$7.9M-5.5%$8.3M+55.3%$5.4M-21.5%$6.8M-47.6%$13.1M
Inventory$745K-67.5%$2.3M-40.8%$3.9M+108.2%$1.9M+4.6%$1.8M$0-100.0%$192K-82.7%$1.1M-75.6%$4.5M+268.3%$1.2M+43.0%$862K+643.1%$116K+136.7%$49K-90.1%$497K-88.3%$4.3M
Accounts Receivable$47K-94.9%$926K-2.4%$949K$0N/A$0-100.0%$1.1M+126.7%$476K+3073.3%$15K-93.9%$245K-85.5%$1.7M+152.2%$669K+2687.5%$24K-97.8%$1.1M+140.8%$463K
Total Liabilities$47.6M-34.3%$72.4M+114.0%$33.8M+34.0%$25.3M+44.6%$17.5M+45.6%$12.0M-24.1%$15.8M-16.4%$18.9M-3.9%$19.7M+219.0%$6.2M-56.5%$14.2M+179.8%$5.1M-50.0%$10.1M+28.7%$7.9M-39.7%$13.1M
Current Liabilities$30.1M-34.4%$46.0M+124.1%$20.5M+79.4%$11.4M-8.3%$12.5M+24.3%$10.0M-30.6%$14.5M-20.5%$18.2M-4.6%$19.1MN/A$7.7M+68.0%$4.6M-52.5%$9.7M+22.9%$7.9M-38.3%$12.7M
Long-Term Debt$19.2M-41.8%$33.0MN/AN/AN/AN/A$0N/AN/AN/AN/AN/AN/AN/AN/A
Total Equity$55.5M+13.9%$48.8M-49.1%$95.8M+6.8%$89.7M-20.4%$112.8M+1151.6%$9.0M+326.5%-$4.0M-196.6%$4.1M-59.2%$10.1M-27.6%$13.9M+9209.2%-$153K-102.2%$6.9M+505.2%-$1.7M-133.6%$5.1M-53.2%$10.8M
Retained Earnings-$957.3M-11.0%-$862.3M-12.7%-$765.4M-12.1%-$682.5M-8.4%-$629.4M-7.4%-$586.2MN/AN/AN/AN/AN/A-$468.8M-4.0%-$450.7MN/AN/A

Not reported in any period shown, so not listed: Goodwill.

MVIS Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

MVIS annual cash flow statement
MetricTTMFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11
Operating Cash Flow-$67.5M-$58.7M+14.3%-$68.5M-2.2%-$67.1M-76.5%-$38.0M-29.3%-$29.4M-82.9%-$16.1M+33.1%-$24.0M-6.5%-$22.6M-45.8%-$15.5M-4.4%-$14.8M-154.4%-$5.8M+55.0%-$13.0M-2.3%-$12.7M+38.6%-$20.6M+26.1%-$27.9M
Capital Expenditures$820K$679K+81.6%$374K-80.7%$1.9M-55.6%$4.4M+74.8%$2.5M+520.1%$402K-46.0%$745KN/AN/AN/AN/AN/AN/AN/AN/A
Free Cash Flow-$68.3M-$59.4M+13.8%-$68.9M+0.2%-$69.0M-62.9%-$42.4M-32.9%-$31.9M-93.6%-$16.5M+33.5%-$24.8MN/AN/AN/AN/AN/AN/AN/AN/A
Investing Cash Flow-$18.5M-$24.6M-1022.5%$2.7M-87.8%$21.8M+157.3%-$38.1M-7.8%-$35.3M-28813.8%$123K+116.5%-$745K+33.4%-$1.1M+63.2%-$3.0M-241.3%-$891K+21.8%-$1.1M-559.0%-$173K+49.1%-$340K-269.6%-$92K-154.1%$170K
Financing Cash Flow$39.0M$60.9M-16.5%$72.9M+0.6%$72.4M+406.3%$14.3M-89.1%$131.2M+386.2%$27.0M+60.0%$16.9MN/AN/AN/AN/AN/AN/AN/AN/A

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.

MVIS Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

MVIS annual financial ratios
MetricFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11
Gross Margin-1435.4%-60.4%-122.2pp61.8%-23.1pp84.9%-15.0pp99.9%+45.2pp54.8%+51.1pp3.6%-36.0pp39.6%+41.9pp-2.4%-32.1pp29.7%+7.9pp21.9%-48.2pp70.0%+0.8pp69.2%+52.0pp17.2%-132.6%
Operating Margin-6856.6%-1821.1%-1224.3%-8116.0%-1754.8%-440.6%-297.9%-154.6%-264.5%-111.5%-158.4%-377.9%-257.9%-270.8%-641.5%
Net Margin-7862.7%-2063.8%-1141.2%-7995.6%-1728.0%-441.2%-298.0%-154.8%-264.5%-111.6%-158.3%-519.9%-225.2%-271.3%-637.5%
Return on Equity-171.0%+27.7pp-198.7%-112.3pp-86.5%-27.3pp-59.2%-20.9pp-38.3%+113.0pp-151.3%N/A-661.9%-409.2pp-252.7%-134.5pp-118.2%N/A-263.7%N/A-449.0%-117.5pp-331.5%
Return on Assets-92.1%-12.1pp-80.0%-16.1pp-63.9%-17.7pp-46.2%-13.0pp-33.2%+31.7pp-64.9%+158.8pp-223.7%-105.4pp-118.3%-32.7pp-85.6%-3.7pp-81.9%+21.6pp-103.6%+48.1pp-151.7%+4.3pp-156.0%+19.4pp-175.4%-25.4pp-150.0%
Current Ratio2.69+0.9x1.79-2.4x4.23-3.7x7.96-1.6x9.58+7.8x1.75+1.2x0.54-0.4x0.97-0.2x1.22N/A1.44-0.7x2.10+1.5x0.60-0.6x1.23-0.2x1.46
Debt-to-Equity0.35-0.3x0.68+0.3x0.35+0.1x0.28+0.1x0.15-1.2x1.33N/A4.59+2.6x1.95+1.5x0.44N/A0.74N/A1.56+0.4x1.21
FCF Margin-4917.1%-1467.5%-950.9%-6382.2%-1275.9%-533.2%-279.0%N/AN/AN/AN/AN/AN/AN/AN/A

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Gross Margin, Operating Margin, Net Margin, FCF Margin.

Similar Companies

Frequently Asked Questions

What is Microvision's annual revenue?

Microvision (MVIS) reported $1.2M in total revenue for fiscal year 2025. This represents a -74.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Microvision's revenue growing?

Microvision (MVIS) revenue declined by 74.3% year-over-year, from $4.7M to $1.2M in fiscal year 2025.

Is Microvision profitable?

No, Microvision (MVIS) reported a net income of -$95.0M in fiscal year 2025.

Microvision (MVIS) reported diluted earnings per share of -$0.35 for fiscal year 2025. This represents a 23.9% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Microvision (MVIS) had EBITDA of -$77.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2025, Microvision (MVIS) had $32.4M in cash and equivalents against $19.2M in long-term debt.

Microvision (MVIS) has a return on equity of -171.0% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Microvision (MVIS) recorded an outflow of $59.4M in free cash flow during fiscal year 2025. This represents a 13.8% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Microvision (MVIS) recorded an outflow of $58.7M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

Microvision (MVIS) had $103.1M in total assets as of fiscal year 2025, including both current and long-term assets.

Microvision (MVIS) invested $679K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Microvision (MVIS) invested $31.7M in research and development during fiscal year 2025.

Microvision (MVIS) had 20M shares outstanding as of fiscal year 2025.

Microvision (MVIS) had a current ratio of 2.69 as of fiscal year 2025, which is generally considered healthy.

Microvision (MVIS) had a debt-to-equity ratio of 0.35 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Microvision (MVIS) had a return on assets of -92.1% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Based on fiscal year 2025 data, Microvision (MVIS) had $32.4M in cash against an annual operating cash burn of $58.7M. This gives an estimated cash runway of approximately 7 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

Microvision (MVIS) has an Altman Z-Score of -14.40, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Microvision (MVIS) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Microvision (MVIS) reported a net loss of $95.0M while operations used $58.7M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Microvision (MVIS) reported an operating loss of $82.8M against $7.3M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Microvision (MVIS) scores 52 out of 100 on our Financial Health Score, indicating moderate standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top